Oncolys BioPharma Inc.
4588 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区虎ノ門４−１−２８虎ノ門タワーズオフィス１０階
- Website:
- https://www.oncolys.com/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Oncolys BioPharma Inc. is a Japanese biotechnology company dedicated to advancing cancer care through innovative therapies and diagnostics. With a focus on both early and late-stage treatment solutions, Oncolys develops groundbreaking approaches in areas such as early detection, loco-regional therapy, prognostic testing, and systemic treatments. The company's mission is to support patients and healthcare professionals alike by delivering effective and novel drugs that enhance cancer treatment outcomes. Through continuous evolution and commitment to research, Oncolys BioPharma aims to transform the landscape of cancer therapy and improve the quality of life for those affected by the disease.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-18 08:30 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 877.6 KB | |
| 2025-03-31 03:16 |
Inside Information Statement
臨時報告書
|
Japanese | 27.7 KB | |
| 2025-03-28 02:16 |
Internal Control over Financial Reporting
内部統制報告書－第21期(2024/01/01－2024/12/31)
|
Japanese | 22.6 KB | |
| 2025-03-28 02:15 |
Annual Report
有価証券報告書－第21期(2024/01/01－2024/12/31)
|
Japanese | 1.2 MB | |
| 2025-03-28 02:15 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-08-09 08:07 |
Regulatory News Service
確認書
|
Japanese | 8.8 KB | |
| 2024-08-09 08:07 |
Interim Report
半期報告書－第21期(2024/01/01－2024/12/31)
|
Japanese | 262.0 KB | |
| 2024-06-14 08:00 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 785.1 KB | |
| 2024-05-10 08:08 |
Regulatory News Service
確認書
|
Japanese | 8.8 KB | |
| 2024-05-10 08:07 |
Quarterly Report
四半期報告書－第21期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 213.8 KB | |
| 2024-04-03 02:44 |
Inside Information Statement
臨時報告書
|
Japanese | 24.1 KB | |
| 2024-03-29 01:21 |
Annual Report
有価証券報告書－第20期(2023/01/01－2023/12/31)
|
Japanese | 1.3 MB | |
| 2024-03-29 01:20 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-03-29 01:19 |
Internal Control over Financial Reporting
内部統制報告書－第20期(2023/01/01－2023/12/31)
|
Japanese | 22.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI | |
|
Bonyf N.V. | Belgium | MLBON | |
|
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
| BrightPath Biotherapeutics Co., Ltd. | Japan | 4594 | ||
|
Calliditas Therapeutics | Sweden | CALTX | |
|
Camurus | Sweden | CAMX | |
| CanBas Co.,Ltd. | Japan | 4575 | ||
|
Cannabotech Ltd. | Israel | CNTC |